Oxymatrine Inhibits Renal Cell Carcinoma Progression by Suppressing β-Catenin Expression

Oxymatrine Inhibits Renal Cell Carcinoma Progression by Suppressing β-Catenin Expression

AimsOxymatrine (OMT) has been identified to possess immunomodulatory, antiinflammatory and anticancer properties. This study aimed to investigate its precise function and the underlying molecular mechanisms in renal cell carcinoma progression.MethodsThe antineoplastic effect of oxymatrine was invest...

Full description

Bibliographic Details
Main Authors: Yinshan Jin, Jiannan Liu, Yadong Liu, Yang Liu, Guiying Guo, Shiliang Yu, Ruihua An
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Pharmacology
Subjects:
oxymatrine
renal cell carcinoma
β-catenin
proliferation
apoptosis
migration
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00808/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.00808/full

Similar Items